FutureTechDose https://validator.w3.org/feed/docs/rss2.html CRISPRa Restores a Youth-Linked Signal in Ageing Mouse Neural Stem Cells Circular RNA Rejuvenates Lab-Grown Stem Cells Without Crossing Into Pluripotency An Antihistamine-Inspired Nanoparticle Carries RNA Into Animal Brains Europe Opens Its Grid-Flexibility Model Before It Sets the Numbers Persistent KV Memory Pushes AI Inference State Onto Shared Flash Singapore’s SG6 Opens With 8 MW and a 1.20 PUE Design Target Six Months in a Dish Creates a Faster Model of Human Cellular Ageing A 42% Response Rate Secures Accelerated Approval in Treated Head-and-Neck Cancer A Fly-Derived Protein Capsule Delivers CRISPR Into Mouse Muscle One Antibody Library Finds 30-Fold Affinity Gains Without Sacrificing Stability Google’s $15 Billion Malaysia Expansion Puts Water and Power Under the Microscope An IL-12 mRNA Injection Produced Early Signals in a 61-Patient Cancer Trial Cancer’s Translation Errors Become a Switch for a Synthetic Gene Circuit India Backs 92 GWh of Grid Storage Across Batteries, Pumped Hydro and Emerging Tech Qualcomm’s HBC Silicon Moves AI Inference Closer to Memory Oracle Drops Government NDAs as Data-Centre Secrecy Faces Scrutiny Drug-Switched IL-15 Gives Engineered TIL Therapy an Internal Control A Defined Microbial Consortium Cuts Bloodstream Infections in a Small Transplant Trial Direct Sickle-Cell Mutation Repair Clears the Manufacturing Test for Human Trials GE Vernova’s $9 Billion Trench Deal Targets a Hidden Grid Bottleneck OpenAI’s Grid Protectors Pilot Turns AI Compute Into Flexible Demand Drax’s £20 Billion Data-Centre Plan Starts With 100 MW and No Tenant Senolytic Trials Have Reached Humans, but Proof Remains Thin VOLGA Trial Puts a New Perioperative Regimen Ahead in Bladder Cancer Sequence Display Teaches Compact Cas9 to Reach Difficult DNA Targets Home mRNA Turns Stem Cells Into Temporary Nerve-Growth-Factor Factories Eight Nuclear-Fuel Projects Aim to Recycle Transuranic Waste USFP Optics Promise 12.8 Tb/s Without Another Network Tier Trastuzumab Botidotin More Than Doubles Tumour-Control Time in Phase III Prime Editing Reaches Its First In-Vivo Human Test for Wilson Disease AMD’s Helion Rack Treats AI Agents as a CPU Problem Too One Splicing Factor Slowed Frailty in Old Mice, Not Human Ageing A Bispecific HER2 Antibody Extends Tumour Control but Adds Toxicity Natural-Language Protein Design Works in the Lab, Not Yet as a Drug Engine Millions of Random Gene Combinations Teach Mammalian Cells New Metabolic Routes The US Grid’s $237 Million Bottleneck Plan Starts With Old Transformers Targeted mRNA Nanoparticles Cut HIV DNA in Cells, Not in Patients Rio Tinto’s 360 MWh Heat Battery Still Has a 12-Month Gate to Clear A 1.2 GW Adelaide Hills AI Campus Has No Development Application Yet Eight Years of Blood Data Show There Is No Single Molecular Ageing Track Google’s Agent Compute Engine Treats Idle Time as the Infrastructure Problem Z Squared’s 150 MW AI-Campus Target Starts With 8 MW and No Tenant A 375,000-Cell Atlas Maps How Human Blood Vessels Age Britain Will Trade Faster Grid Access for Data-Centre Obligations A TROP2 Antibody–Drug Conjugate Extends Lung-Cancer Control in Phase III Six Patients Put In-Vivo Base Editing Through an Early Human Test A 120-Base RNA Switch Gives Gene Therapy a Drug-Controlled Dial India’s New 500 MWh Battery Project Turns a Storage Contract Into Grid Capacity Blog